Compare stocks
Market: US
LLYLilly (Eli)
Add stock
Ticker or company
Summary

LLY
Lilly (Eli)
$1 431,67Down −0,82%
Year: Up +41%
75/100★★★★★★★★★Ratio would consider buying
Open stock pageTraffic light — 10 checks
| Check | LLY5 ✓ 2 — 1 ✕ |
|---|---|
| P/E vs its history | 49,2 |
| P/E vs industry | 49,2 |
| Forward P/E | 30,6 |
| Revenue growth, YoY | +45,5% |
| EPS growth, YoY | +50,7% |
| Net margin | 31,9% |
| Net debt / EBITDA | n/a— |
| Free cash flow | $30,6 bn |
| Share count over a year | −0,6% |
| Cash runway | n/anot needed |
Metrics
Best WorstNo mark — in between
| Metric · better | LLYTTM | Industry medianTTM |
|---|---|---|
| P/E TTM ↓ | 49,2 | 41,8 |
| Forward P/E ↓ | 30,6 | 12,4 |
| PEG ↓ | 1,4 | 3,3 |
| P/S TTM ↓ | 15,7 | 3,4 |
| EV/EBITDA ↓ | 37,9 | 24,0 |
| P/FCF ↓ | 116,2 | 14,0 |
Price, %
- LLYn/a
Returns
Best WorstNo mark — in between
| Period | LLY |
|---|---|
| 1 year | n/a |
| 3 years | n/a |
| 5 years | n/a |
| All time | n/a |
“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.
Analysts and insiders
Best WorstNo mark — in between
| LLY | |
|---|---|
| Share of “buy” | 86% |
| Beat the forecast | 4 of 4 |
| Average “surprise” | +23,9% |
| Insiders over 12 months | sales $1,09 bn |
Details are on each stock page.